Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
atypical antipsychotics
Manufacturing
Rovi wins FDA nod to make Moderna's COVID shot at Spanish plant
Rovi CEO Juan López-Belmonte sees Novo Nordisk's acquisition of Catalent as a “tremendous opportunity” for his company to win more customers.
Angus Liu
Feb 28, 2024 11:22am
Teva taps Royalty to bankroll long-acting schizophrenia drug
Nov 13, 2023 11:40am
Takeda, AstraZeneca, Astellas and more—Fierce Pharma Asia
May 19, 2023 9:25am
Intra-Cellular's Caplyta posts sweeping win in depression trial
Mar 29, 2023 11:30am
Acadia's Nuplazid gets second FDA complete response letter
Aug 5, 2022 11:26am
FDA panelists vote down Acadia's proposed Nuplazid expansion
Jun 21, 2022 11:00am